These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 11944029

  • 1. Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.
    Martín S, Pedro-Botet J, Joven J, Simó JM, Ladona MG, Pavesi M, Rubiés-Prat J.
    J Lab Clin Med; 2002 Mar; 139(3):181-7. PubMed ID: 11944029
    [Abstract] [Full Text] [Related]

  • 2. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
    Saku K, Zhang B, Liu R, Shirai K, Arakawa K.
    Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting.
    Martín S, Ladona MG, Pedro-Botet J, Covas MI, Rubiés-Prat J.
    Clin Chim Acta; 1998 Oct; 277(2):191-205. PubMed ID: 9853702
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.
    Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, Vaduganathan M, Rao RS, Koschinsky M, Morrisett JD.
    J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835
    [Abstract] [Full Text] [Related]

  • 5. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
    Farrer M, Game FL, Albers CJ, Neil HA, Winocour PH, Laker MF, Adams PC, Alberti KG.
    Arterioscler Thromb; 1994 Aug; 14(8):1272-83. PubMed ID: 8049188
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
    Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna L, Geroldi D.
    Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
    [Abstract] [Full Text] [Related]

  • 7. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH, Fortmann SP, Marcovina SM.
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B, Lupattelli G, Siepi D, Bianchi A, Anniboletti PF, Blandini V, Sinzinger H, Mannarino E, Palumbo R.
    Wien Klin Wochenschr; 2002 Dec 30; 114(23-24):987-91. PubMed ID: 12635466
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G, Taddei-Peters WC, Költringer P, Petek W, Chen Q, Greilberger J, Macomber PF, Butman BT, Stead AG, Ransom JH.
    Stroke; 1995 Oct 30; 26(10):1841-8. PubMed ID: 7570736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
    Akanji AO.
    Ann Clin Biochem; 2000 May 30; 37 ( Pt 3)():360-6. PubMed ID: 10817252
    [Abstract] [Full Text] [Related]

  • 13. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM, Joven J, Vilella E, Ribas M, Pujana MA, Sundaram IM, Hammel JP, Hoover-Plow JL.
    Thromb Haemost; 2001 Mar 30; 85(3):412-7. PubMed ID: 11307806
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein(a) and coronary heart disease.
    Rodriguez CR, Seman LJ, Ordovas JM, Jenner J, Genest MS, Wilson PW, Schaefer EJ.
    Chem Phys Lipids; 1994 Jan 30; 67-68():389-98. PubMed ID: 8187239
    [Abstract] [Full Text] [Related]

  • 15. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B, Després JP, Lamarche B, Moorjani S, Lupien PJ, Bogaty P, Bergeron J, Dagenais GR.
    Am J Cardiol; 2002 Mar 15; 89(6):662-6. PubMed ID: 11897206
    [Abstract] [Full Text] [Related]

  • 16. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men.
    Paultre F, Pearson TA, Weil HF, Tuck CH, Myerson M, Rubin J, Francis CK, Marx HF, Philbin EF, Reed RG, Berglund L.
    Arterioscler Thromb Vasc Biol; 2000 Dec 15; 20(12):2619-24. PubMed ID: 11116062
    [Abstract] [Full Text] [Related]

  • 17. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
    Barra S, Cuomo V, Silvestri N, Materazzi C, Vitagliano G, Capozzi G, Caruso S, Gaeta G, Trevisan M.
    J Cardiovasc Med (Hagerstown); 2011 Jul 15; 12(7):482-6. PubMed ID: 21519277
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
    Ishikawa S, Deguchi T, Hara K, Takuma S, Kayaba K, Tsutsumi A, Kario K, Igarashi M.
    J Epidemiol; 1999 Feb 15; 9(1):32-9. PubMed ID: 10098351
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G.
    J Clin Invest; 1992 Mar 15; 89(3):1040-6. PubMed ID: 1541665
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.
    Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A, Elisaf MS.
    Thyroid; 2003 Apr 15; 13(4):365-9. PubMed ID: 12804105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.